CorneaGen

CorneaGen is developing new technologies for corneal tissue transplantation. Loss of sight caused by damage to the surface of the eye leaves millions of people worldwide with corneal blindness. Treating and caring for every person impacted by corneal disease with the highest quality donor tissue is CorneaGen’s mission. To achieve this, CorneaGen has innovated in tissue processing technology and surgical devices becoming now the world’s leading eye bank. CorneaGen has built a comprehensive portfolio of corneal transplant tissue including their revolutionary EndoSerter®-PL, an FDA approved, single-use graft insertion device that is preloaded with Nano-ThinTM tissue.

Jobs: